JP2002087964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002087964A5 JP2002087964A5 JP2000263735A JP2000263735A JP2002087964A5 JP 2002087964 A5 JP2002087964 A5 JP 2002087964A5 JP 2000263735 A JP2000263735 A JP 2000263735A JP 2000263735 A JP2000263735 A JP 2000263735A JP 2002087964 A5 JP2002087964 A5 JP 2002087964A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- testosterone
- isopropyl myristate
- active pharmaceutical
- pharmaceutical ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 description 10
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical group O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- 229960003604 testosterone Drugs 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 239000003961 penetration enhancing agent Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000263735A JP5039252B2 (ja) | 2000-08-31 | 2000-08-31 | 性機能低下を治療するための医薬組成物及び方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000263735A JP5039252B2 (ja) | 2000-08-31 | 2000-08-31 | 性機能低下を治療するための医薬組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002087964A JP2002087964A (ja) | 2002-03-27 |
| JP2002087964A5 true JP2002087964A5 (enrdf_load_html_response) | 2007-10-11 |
| JP5039252B2 JP5039252B2 (ja) | 2012-10-03 |
Family
ID=18751240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000263735A Expired - Lifetime JP5039252B2 (ja) | 2000-08-31 | 2000-08-31 | 性機能低下を治療するための医薬組成物及び方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5039252B2 (enrdf_load_html_response) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7029694B2 (en) * | 2000-04-26 | 2006-04-18 | Watson Laboratories, Inc. | Compositions and methods for transdermal oxybutynin therapy |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US20070088012A1 (en) * | 2005-04-08 | 2007-04-19 | Woun Seo | Method of treating or preventing type-2 diabetes |
| AU2006235453A1 (en) * | 2005-04-12 | 2006-10-19 | Laboratories Besins International | Method of treating or preventing bone deterioration or osteoporosis |
| CA2624788C (en) | 2005-10-12 | 2011-04-19 | Unimed Pharmaceuticals, Llc | Improved testosterone gel and method of use |
| JP6457899B2 (ja) * | 2015-07-22 | 2019-01-23 | アズビル株式会社 | 標準信号発生器 |
| JP7121999B2 (ja) * | 2019-09-26 | 2022-08-19 | 学校法人九州文化学園 | 男性性腺機能低下症治療剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4036496B2 (ja) * | 1995-10-24 | 2008-01-23 | リンテック株式会社 | ゲル製剤の製造方法 |
| DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
| ATE418988T1 (de) * | 1997-11-10 | 2009-01-15 | Strakan Int Ltd | Penetrationsfördernde und irritationsvermindernde systeme mit testosteron |
| DE60141587D1 (de) * | 2000-08-30 | 2010-04-29 | Besins Int Lab | Verfahren zur behandlung von erektionsstörungen und steigerung der libido bei männern |
-
2000
- 2000-08-31 JP JP2000263735A patent/JP5039252B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003233653B2 (en) | Compositions and method for transmucosal drug delivery and cryoprotection | |
| JP2004524267A5 (enrdf_load_html_response) | ||
| AU725283B2 (en) | Bioadhesive pharmaceutical composition for the controlled release of active principles | |
| AU2010299607B2 (en) | Formulations comprising triptan compounds | |
| HUP0302921A2 (hu) | Hatóanyag perkután bejuttatására alkalmas alkoholos gélkészítmény, valamint ebből egységdózist tartalmazó csomag | |
| CO5160329A1 (es) | Metodo para proveer absorcion incrementada de una amina far- maceuticamente aceptable en la sangre de un humano y composi cion que comprende una amina farmaceuticamente un farmaco antiinflamatorio no esteroidal | |
| US20030072814A1 (en) | Topical pharmaceutical composition for the treatment of warts | |
| ES2175799T3 (es) | Forma de dosificacion para administracion en aerosol. | |
| JP2004534839A5 (enrdf_load_html_response) | ||
| AU2681300A (en) | Solid oral dosage form containing an enhancer | |
| JP2003512393A5 (enrdf_load_html_response) | ||
| RU2004124720A (ru) | Плоский или пластинчатый лекарственный препарат с исправленным вкусом | |
| JP2012513955A5 (enrdf_load_html_response) | ||
| RU2004106779A (ru) | Способ профилактики и/или лечения дисфункции и/или нарушения структуры ногтей, пластырь для его осуществления и его применение | |
| EP1365749A4 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS | |
| JP2009518374A (ja) | 活性薬剤、特にジクロフェナクの経皮投与 | |
| WO2009113051A3 (en) | Oral modified-release formulations containing thiazepines | |
| MXPA05011724A (es) | Productos dulces para liberar agentes farmaceuticamente activos a la garganta. | |
| JP2002087964A5 (enrdf_load_html_response) | ||
| JP2023520845A (ja) | ヒドロキシクロロキン及び／又はクロロキンを含む経口送達システム | |
| JP2006516141A5 (enrdf_load_html_response) | ||
| JP2002537232A5 (enrdf_load_html_response) | ||
| NZ547376A (en) | Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a non-aqueous vehicle | |
| JP2023521563A (ja) | ヒドロキシクロロキン及び／又はクロロキンを含む経皮及び／又は局所送達システム | |
| JP2002537246A5 (enrdf_load_html_response) |